AETHLON MEDICAL INC（AEMD）美股招股说明书 S-1（2026-07-01修订版）（英文版）（61页）.pdf

1、Table of Contents As filed with the Securities and Exchange Commission on July 1,2026.Registration Statement No.333-296933 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 PRE EFFECTIVE AMENDMENT NO.1TOFORM S-1REGISTRATION STATEMENTUnderTHE SECURITIES ACT OF 1933 AETHLON MEDICAL,I

2、NC.(Exact name of registrant as specified in its charter)Nevada 3826 13-3632859(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)11555 Sorrento Valley Road,Suite 203San Diego,CA 92121(619)941-0360(

3、Address,including zip code,and telephone number,including area code,of registrants principal executive offices)James B.FrakesChief Executive Officer&Chief Financial OfficerAethlon Medical,Inc.11555 Sorrento Valley Road,Suite 203San Diego,CA 92121(619)941-0360(Name,address,including zip code,and tele

4、phone number,including area code,of agent for service)Copies to:Dennis Doucette,Esq.Procopio Cory Hargreaves&Savitch,LLP12544 High Bluff DriveSuite 400San Diego,CA 92130Telephone:(858)720 6322Fax:(858)720 6303 M.Ali PanjwaniPryor Cashman LLP;7 Times SquareNew York,NY 10036-6569Telephone:(212)326-084

5、6Fax:(212)326-0806 Approximate date of commencement of proposed sale to public:As soon as practicable after this Registration Statement isdeclared effective.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securit

6、ies Act of 1933,check the following box.x If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check thefollowing box and list the Securities Act registration statement number of the earlier effective registration statement for the s